DataRx - Real World Data to lead insights for medical innovation
Established in 2016, DataRx is now a top leading medical big data company with collaboration with the most and by far the largest number of cutting-edge research partners in China.
Medical progress using Advanced AI / ML technologies captures the value of real world data like never before. We innovate to bring forth the benefits of better treatment, medical research, and optimised solutions for drug discovery.
With a cross disciplinary team with in-depth medical and informatics knowledge, patient well-being is at the heart of what we do.
Data is vital to
our work
As a leading medical big data solution provider, our data model covers major disease groups and medical conditions.
DataRx holds access to medical information that is fully de-identified and cleansed, ensuring the HIPAA guidelines are followed strictly and hence to guarantee the privacy of the patients.
Collaboration Research
DataRx actively contributes to the research efforts across the globe to advance the development of biomedical science using real-world, multidisciplinary knowledge from experts of each field.
Our platform and technologies empower every researcher to be a part of a global network united in our shared commitment to patient well-being.
DataRx's Analysis
Platform
DataRx provides a unique analysis platform to transform historical data into new insight and to promote innovative applications of medical big data.
Using advanced Artificial Intelligence / Machine Learning technologies, the platform comprehensively assist clinical researchers in acquiring and analysing data to improve disease detection, diagnosis, treatment and management.
The Value We Bring
To find out more, click on each section for specific case studies
Our Clients and Collaboration Partners
Our Achievements & Investment Opportunities
Copyright & Patent
Since DataRx's establishment, the company has obtained eleven Software Copyright Certificates from NCAC (National Copyright Administration of The People's Republic of China) and two Patent Certificates.
These innovations allow us to keep at the forefront of medical big data and use our knowledge to better the community.